EUROPEAN DRUG PREVENTION PRIZE
Youth Innovation in Drug Prevention
The Pompidou Group's European Drug Prevention Prize was first launched in 2004. It is awarded every two years. In each two-year cycle,
up to three prizes are awarded. The 2016 Prize is the seventh cycle. Information about the 2014 prize winners is
here. You can find information about earlier
prize-winners by following the links in the 'Successful Projects' box on this webpage
Prize-winners are high-quality drug prevention projects that fully involve young people. Young people are involved in the development and implementation of activities,
in project decisions, in project management and perhaps in project evaluation.
The Pompidou Group awards the Prize to highlight high-quality drug prevention projects that have proved successful in practice in
involving young people. It aims to encourage the development of drug prevention work where young people are actively participating. The Pompidou Group believes that
the genuine involvement of young people improves the possibilities of successful drug prevention.
The projects which apply are evaluated by a Jury of seven young people (aged between 16 and 21 at the time of their appointment) recruited from the Pompidou Group's
and Council of Europe member States. The jurors are selected by the Pompidou Group based on their experience of youth participation in drug prevention. Jurors serve for two terms.
In 2016, three of the jurors served for the 2014 Prize and four are new to the Jury. In 2016, the jurors come from France, Germany, Iceland, Israel, Morocco, Poland
and Slovenia. The Jury is advised by a former juror and by a drug prevention expert, but only jury members take the decisions on awarding the Prize.
The prize-winners each receive a trophy, a diploma and a prize-money of €5.000. Previous prize-winners say that the recognition of their value by the Pompidou
Group has been invaluable in helping them to secure funding.
The Call for Applications for the Pompidou Group's 2016
European Drug Prevention Prize opens on 1 April 2016.
Applications are sought from all member States of the Pompidou
Group and of the Council of Europe as well as the MedNET
countries. See the box below for the list of eligible
Further details are in the document,
Concept, Rules and Procedures
Applications must use the
2016 Application Form.
You must submit your application by Sunday, 31 July 2016.
Applications must be sent by email to:Pompidou.email@example.com
Supporting material can be submitted by email, electronic link,
or if necessary, by post (see application form for details).
If you have any questions about the Prize or about your application,
FAQs. if you still have questions, then please
The 2016 Prize Jury met in Strabsourg
in March 2016. This was an opportunity for the four new
jurors to meet the experienced jurors who had served in
the 2014 Prize Jury and who are continuing on the 2016 Jury
(jurors serve for two Prize Cycles). The jurors considered
the criteria that they will use to assess the value of the
applicant projects. They also learned more about the
institutions of the Council of Europe, such as the European
Court of Human Rights.
Follow us on
Countries eligible to apply for the Pompidou Group's European Drug PreventionPrize
47 Council of Europe member States
(Pompidou Group member States in bold):
Albania, Andorra, Armenia, Austria, Azerbaijan, Belgium,
Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus,
Czech Republic, Denmark, Estonia, Finand, France,
Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy,
Latvia, Liechtenstein, Lithuania, Luxembourg, Malta,
Moldova, Monaco, Montenegro, Netherlands, Norway, Poland,
Portugal, Romania, Russian Federation, San Marino, Serbia,
Slovak Republic, Slovenia, Spain, Sweden, Switzerland,
"The former Yugoslav Republic of Macedonia", Turkey,
Ukraine, United Kingdom.
Other Pompidou Group member States
Pompidou Group observer State
Algeria, Egypt, Jordan, Lebanon, Tunisia